Access cutting-edge ocular melanoma treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access ocular melanoma specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ocular melanoma treatment provided free
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma
Sponsor: IDEAYA Biosciences
Check if you qualify for this ocular melanoma clinical trial in Rochester, MN
If you're searching for ocular melanoma treatment options in Rochester, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ocular melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.